Abstract
A series of HIV-1 protease inhibitors based on the lead compound Pc (IC50 = 165 nmol/l) with structural modifications at P1/P1' substituents or with a lengthening at its core unit were synthesized from amino acid starting materials. All analogues were less active than Pc against the protease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 564-568 |
| Number of pages | 5 |
| Journal | Arzneimittel-Forschung/Drug Research |
| Volume | 50 |
| Issue number | 6 |
| DOIs | |
| State | Published - 2000 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- HIV-1 protease inhibitors
- Peptidomimetics
Fingerprint
Dive into the research topics of 'Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS